24 June 2024
Specialists at the Gamaleya National Center of Epidemiology and Microbiology have successfully developed a drug for the urgent prevention and treatment of botulism. Preclinical trials have already been completed, and the development is now advancing to clinical trials. Russian Health Minister Mikhail Murashko shared this information with reporters.
“Over the last year, we have been developing a new drug for the treatment of this type of infection – this is a new modern drug. He has now completed preclinical studies, and we will begin clinical studies in the coming days,” he said.
As previously stated by Dmitry Shcheblyakov, head of the Laboratory of Immunobiotechnologies at the National Medical Research Center, the clinical trial could be completed by 2025.
Print06 September 2024
NovaMedica expands its line of products for the treatment of Alzheimer’s disease
22 August 2024
Children visited the NovaMedica Innotech pharmaceutical manufacturing facility
14 June 2024
From January to August 2024, Russia’s medicinal product production totaled 530.7 billion rubles
27 September 2024
The government has expanded medicine sales in villages without pharmacies
27 September 2024
FDA issues draft guidance to help industry conduct global cancer clinical trials
26 September 2024
Optimizing Patient Support Through Effective Information Governance: Balancing Risks and Rewards
26 September 2024